Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
United Kingdom (3)
Pharmaceutical, Biotech, Medical Device Company (0)
Payers (usually governmental or public bodies, reimbursement)
Capacity and capabilities for engagement
Clinical study phase I